MAZE (Maze Therapeutics) FFO


MAZE Maze Therapeutics Inc MAZE
14 GF Score
Price $27.03
! 2 Warning Signs
View Full Analysis

What is Maze Therapeutics FFO?

FFO (Funds from operations) only applies to REITs.

MAZE
14GF Score
Maze Therapeutics Inc MAZE
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Maze Therapeutics Business Description

Address 171 Oyster Point boulevard, Suite 300, South San Francisco, CA, USA, 94080
Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular, and related metabolic, or CVRM, diseases, including obesity. The company is advancing a pipeline using its Compass platform, which allows the company to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. It is currently advancing two programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease, or CKD.
14GF Score

Get the complete analysis for MAZE

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$27.03
Price